Posts Tagged ‘research’
Bladder Cancer Discovery: Immunotherapy as Maintenance Treatment
Bladder cancer is the sixth most common cancer in the United States. Bladder cancer is usually diagnosed at “superficial” or non-invasive stages, when it only involves the lining of the bladder and can be treated with removal of the cancerous tissue alone. However, some patients develop high-risk tumors that are likely to come back and…
Read MoreSports Medicine Research: Pushing Limits to Improve Patient Care
Medical treatments should always be based on the best available evidence. But sometimes, the best evidence isn’t good enough. “We should always be looking to get better,” said Edward Chang, MD, an orthopedic surgeon and researcher at Inova Sports Medicine. That mission is why Inova Sports Medicine investigators are working on a number of exciting…
Read MoreFDA Approves Cutting-Edge Cancer Drug from Inova Schar Cancer Institute Clinical Trial
Inova’s Dr. John Deeken served as the site principal investigator for this prestigious study In groundbreaking news for the medical and cancer research community, the Food and Drug Administration (FDA) approved a new, breakthrough cancer drug, larotrectinib, or Vitrakvi®, that targets specific genetic mutations in adult and pediatric patients. This is only the second tissue-agnostic…
Read MoreNPR Visits Inova to Document Infant-Health Research Study
Inova’s vaginal seeding study featured on NPR’s Morning Edition NPR’s Morning Edition has profiled the groundbreaking vaginal seeding study at Inova Women’s Hospital that aims to discover if babies born by C-section will benefit from a swab of their mother’s microbes. The article explains how vaginal seeding “was developed in response to the sharp rise…
Read MoreInova cardiac researchers publish JAMA article on use of intensive lipid-lowering drugs
The question over who should use cholesterol reducing medication is a hotly debated topic among physicians. Researchers at Inova just published an analysis in the current edition of the Journal of the American Medical Association (JAMA) providing foundational findings that will help change the understanding of when and how to use intensive lipid-lowering therapy to…
Read MoreThe Society for Women’s Health Research Elects Roberta L. Gartside, MD, as Incoming Chair of Its Board of Directors
Washington, DC —The Society for Women’s Health Research (SWHR) announced the unanimous election of Roberta L. Gartside, MD, as the new Chair of its Board of Directors for 2018-2019. As a business leader with a strong commitment to nonprofit service, Dr. Gartside will lead the organization’s mission-based efforts to eliminate imbalances in care for women…
Read MoreResearch Breakthroughs: Advances in Breast Cancer Diagnosis & Treatment
Mary J. Wilkinson, MD, is a medical oncologist. She is board- certified in medical oncology, internal medicine and hematology and has a special interest in breast cancer. A breast cancer diagnosis is always unwelcome news, but new advances in detection and treatment are leading to improvements in cancer care and quality of life. Here are…
Read MoreThe GALILEO Trial: Inova Researchers Study New Drug Therapy for Heart Patients
Matthew W. Sherwood, MD, is board certified in interventional cardiology, cardiovascular disease and internal medicine. He practices at the Inova Heart and Vascular Institute. Read Dr. Sherwood’s profile. Starting in March, we began enrolling patients in a first-of-its-kind study to compare drug therapies for patients who have had transcatheter aortic valve replacement, or TAVR. As…
Read MoreFrom Research to Results: Advances in Genitourinary Cancer Treatment
Jeanny B. Aragon-Ching, MD, is the clinical program director of genitourinary cancers at the Inova Schar Cancer Institute. She is board certified in medical oncology, hematology and internal medicine and has a special interest in caring for patients with prostate, bladder, kidney and testicular cancers. Read Dr. Aragon-Ching’s profile. This February, I’ll be traveling to…
Read MoreChildren’s National and Inova Announce Three-Year, $2.8 million Research and Education Collaboration
Partnership to yield major, nationally competitive research and academic program in maternal, fetal and neonatal medicine WASHINGTON – (January 12, 2017) – Children’s National Health System and Inova this week announced a new three-year, $2.8 million research and education collaboration in maternal, fetal and neonatal medicine that aims to leverage the strengths of both health…
Read More